Unaudited Condensed Consolidated Statements of Stockholders’ Equity - USD ($) $ in Thousands	Total	Common stock	Additional paid-in capital	Accumulated deficit
Balance at beginning (in shares) at Dec. 31, 2024		20,145,129
Balance at beginning at Dec. 31, 2024	$ 63,144	$ 2	$ 274,895	$ (211,753)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock (in shares)		1
Vesting of restricted common stock (in shares)		11,666
Stock-based compensation expense	861		861
Net loss	(12,433)			(12,433)
Balance at ending (in shares) at Mar. 31, 2025		20,156,796
Balance at ending at Mar. 31, 2025	$ 51,572	$ 2	275,756	(224,186)
Balance at beginning (in shares) at Dec. 31, 2025	51,902,614	51,902,614
Balance at beginning at Dec. 31, 2025	$ 47,704	$ 6	339,854	(292,156)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock under employee stock purchase plan (in shares)	15,562
Issuance of common stock under employee stock purchase plan	$ 18
Stock option exercises (in shares)		7,624
Stock option exercises	39		39
Stock-based compensation expense	1,472		1,472
Net loss	$ (18,331)			(18,331)
Balance at ending (in shares) at Mar. 31, 2026	51,925,800	51,925,800
Balance at ending at Mar. 31, 2026	$ 30,902	$ 6	$ 341,383	$ (310,487)